Scientific Validation of Ozics Technology in Osteoporotic Bone

"Biomechanical evaluation of bone screw fixation with a novel bone cement" has been published on BioMedical Engineering OnLine confirming the good biomechanical screw augmentation properties of Ozics' lead product CompO6™ in osteoporotic bone.
By: Ozics Holdings, Ltd.
 
 
Spread the Word
Listed Under

Tags:
Osteoporosis
Fracture
Bone Cement

Industry:
Medical

Location:
Hamilton - Hamilton - Bermuda

Subject:
Reports

HAMILTON, Bermuda - Aug. 18, 2015 - PRLog -- August 18, 2015 Hamilton, Bermuda

Ozics Holdings, Ltd. (www.ozicsholdings.com), a medical device company with high-strength, injectable, biocomposite technology inteded to be used to improve the treatment of fragility fracturesannounced today that the performance of its lead product CompO6 has been confirmed in an independent scientific study published on Issue 14 of BioMedical Engineering OnLine 2015. The article concluded that "Comp06 provided significantly improved fixation of screws in the osteoporotic bone model based on screw pullout testing", and "The improvements achieved with novel bone cements demonstrated their potential to increase the fixation stability in osteoporotic bone compared to conventional bone cement Simplex ® P. Good (bio)mechanical properties exceed the requirements of industry standards. The unique mechanical properties combined with HA-content make these novel bone cements more biological than PMMA bone cement."

The complete article can be found at: http://www.biomedical-engineering-online.com/content/14/1/74.

CEO Auvo Kaikkonen stated, “ We are very pleased with this validation of our technology in one of our key surgical indications, i.e. screw augmentation. This is very important as our products are primarily intended to be used in patients with fragility fractures. The surgeons using CompO6 for screw augmentation can now refer to measurable values when assessing whether or not to improve the purchase of the screws in a clinical procedure involving osteoporotic bone."

About Ozics:

Ozics was founded to develop and commercialize novel, high-strength, injectable, biocomposites to improve the treatment of fragility fractures. Through collaborative partnerships, technology licensing, and internal research and development efforts, Ozics delivers innovative products that are less invasive, improve patient outcomes, and lower the cost of caring for patients with fragility fractures.

Contacts

Ozics Holdings, Ltd


Auvo Kaikkonen, President, Director

tel. +1441 292 7979

auvo.kaikkonen@ozics.com

--- End ---

Contact
Ozics Holdings, Ltd
, Auvo Kaikkonen, President
***@ozics.com
End
Email:***@ozics.com Email Verified
Tags:Osteoporosis, Fracture, Bone Cement
Industry:Medical
Location:Hamilton - Hamilton - Bermuda
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Ozics Group PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share